|
|
|
Volumn 5, Issue 5, 2007, Pages 365-366
|
|
Novel agents and targets for the therapy of advanced colon cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (4 FLUORO 2 METHYL 5 INDOLYLOXY) 6 METHOXY 7 [3 (1 PYRROLIDINYL)PROPOXY]QUINAZOLINE;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
BEVACIZUMAB;
CETUXIMAB;
DASATINIB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
EVEROLIMUS;
FLUOROURACIL;
FOLINIC ACID;
IMATINIB;
IRINOTECAN;
MAMMALIAN TARGET OF RAPAMYCIN;
MITOGEN ACTIVATED PROTEIN KINASE;
MONOCLONAL ANTIBODY;
N (3,3 DIMETHYL 6 INDOLINYL) 2 (4 PYRIDINYLMETHYLAMINO)NICOTINAMIDE;
OXALIPLATIN;
PANITUMUMAB;
PLATELET DERIVED GROWTH FACTOR;
PROTEIN TYROSINE KINASE INHIBITOR;
SORAFENIB;
STEM CELL FACTOR;
STEROID RECEPTOR COACTIVATOR 1;
SUNITINIB;
TAS 102;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VASCULOTROPHIN TRAP;
VASCULOTROPIN;
VATALANIB;
VECTIBIX;
PHTHALAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
ADVANCED CANCER;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER THERAPY;
CLINICAL TRIAL;
COLON CANCER;
COLORECTAL CANCER;
COMBINATION CHEMOTHERAPY;
DRUG INDICATION;
DRUG MECHANISM;
DRUG TARGETING;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
METASTASIS;
PANCREAS CANCER;
CANCER STAGING;
COLON TUMOR;
IMMUNOLOGY;
PATHOLOGY;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
COLONIC NEOPLASMS;
HUMANS;
NEOPLASM STAGING;
PHTHALAZINES;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
|
|
EID: 34548617932
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (6)
|
